Trajan business unit coming to the University of Adelaide

Trajan Scientific and Medical has announced its new Instruments, Sensors and Devices Business Unit, to be located at the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS). The unit will have global responsibilities for new devices, such as the recently revealed hemaPEN for dried blood spot sampling.

Trajan’s goal is for the business unit to become a global centre of excellence for sensing and device technologies. The company’s focus is on developing and commercialising technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements — especially those that can lead to portability, miniaturisation and affordability.

“The opening of the Instruments, Sensors and Devices Business Unit is a significant milestone for Trajan as we expand our footprint from our historical manufacturing hub in Melbourne, Victoria,” said Trajan CEO Stephen Tomisich. “The combination of the location in Adelaide, the collaboration with IPAS and the university, and the expansion of technical capabilities puts us in a strong position to realise our vision of enriching wellbeing.”

Dr Anne Collins has been announced as the general manager of the business unit. With a PhD in Biochemical Engineering from the University College London and an MBA from the University of Adelaide, she possesses more than 20 years of international experience in the pharmaceutical and life science industry. She will be supported by Principal Scientist (Photonics) Dr Herbert Foo.

The announcement comes just two months after Trajan’s strategic collaboration with the University of Adelaide, supported by the South Australian Government, was revealed. The collaboration sees the realisation of the IPAS research and development and manufacturing hub based on a new generation of specialty glass products for the global science and medical equipment market, helping scientists to commercialise their research into products that ultimately benefit human health and wellbeing.

Image caption: Dr Anna Collins.